Mutations in a hydrophilic part of the core gene of hepatitis C virus in patients with hepatocellular carcinoma in China

Journal of Gastroenterology

Volumn 32, Issue 1, 1997, Pages 47-55

  Shimizu, Ichiro ^a   Yao, Deng Fu ^b   Horie, Chiyo ^a   Yasuda, Mitsugi ^a   Shiba, Masako ^a   Horie, Takahiro ^a   Nishikado, Tomoko ^a   Meng, Xian Yong ^b   Ito, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NANTONG MEDICAL COLLEGE   (China)

Author keywords

China; CTL; HCV; Hepatocellular carcinoma; Missense mutation

Indexed keywords

NUCLEOTIDE;

ADULT; AGED; ARTICLE; CHINA; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE CLUSTER; GENE SEQUENCE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MALE; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; VIRUS ISOLATION;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHINA; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 0031053566     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01213296     Document Type: Article

References (48)

1. Ito S, Yao DF, Nu C, et al. Epidemiological characteristics of the incidence of hepatitis C virus (C100-3) antibodies in patients with liver diseases in the inshore area of the Yangtze River. J Gastroenterol Hepatol 1993;8:232-237.
2. Ito S, Yao DF, Nii C, et al. Incidence of hepatitis C virus (HCV) antibodies and HCV-RNA in blood donors and patients with liver diseases in the inshore area of the Yangtze River. J Gastroenterol Hepatol 19943;245-249.
3. Horie C, Horie T, Honda H, et al. Virological features of hepatitis C virus infection in patients with liver diseases in a high-risk region for hepatocellular carcinoma in the inshore area of the Yangtze River (in Japanese). Acta Hepatol Jpn 1995;36:76-84.
4. Yeh FS, Shen KN. Epidemiology and early diagnosis of primary liver cancer in China. Adv Cancer Res 1986;47:297-329.
5. Ross RK, Yuan JM, Yu MC, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992;339:943-946.
6. Hsu IC, Metcalf RA, Sun T, et al. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-428.
7. Saito I, Miyamura T, Ohbayashi A, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6547-6549.
8. Di Bisceglie AM, Order SE, Klein JL, et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991;86:335-338.
9. Colombo M, Rumi MG, Donato MF, et al. Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma. Dig Dis Sci 1991;36:1130-1133.
10. Chen PJ, Lin MH, Tai KF, et al. The Taiwanese hepatitis C virus genome: Sequence determination and mapping the 5′ termini of viral genomic and antigenomic RNA. Virology 1992;188:102-113.
11. Liu K, Hu Z, Li H, Prince AM, Inchauspe G. Genomic typing of hepatitis C viruses present in China. Gene 1992;114:245-250.
12. Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Nad Acad Sci USA 1990;87:9524-9528.
13. Takamizawa A, Mori C, Fuke I, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991;65:1105-1113.
14. Choo QL, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991;88:2451-2455.
15. Okamoto H, Tokita H, Sakamoto M, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993;74:2385-2390.
16. Wang Y, Okamoto H, Tsuda F, et al. Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol 1993;40:254-260.
17. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-679.
18. Kanai K, Kato M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992;339:1543.
19. Ogata N, Alter HJ, Miller RH, Purcell RH, Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991;88:3392-3396.
20. Okamoto H, Kojima M, Okada S, et al. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: Variability and stability. Virology 1992;190:894-899.
21. Weiner AJ, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992;89:3468-3472.
22. Hijikata M, Kato N, Ootsuyama Y, et al. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991;175:220-228.
23. Weiner AJ, Brauer MJ, Rosenblatt J, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991;180:842-848.
24. Mondelli M, Vergani GM, Alberti A, et al. Specificity of lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: Evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 1982; 129:2773-2778.
25. Vento S, Hegarty JE, Alberti A, et al. T lymphocyte sensitization to HBsAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology 1985;5:192-197.
26. b molecule. Nature 1990;348:213-216.
27. Rotzschke O, Falk K, Deres K, et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990;348:252-254.
28. Chinese National Viral Hepatitis Meeting (1990, Shanghai). Diagnostic standard for viral hepatitis (in Chinese). Chin J Intern Med 1991;30:8-16.
29. Shen FM, Lee MK, Gongh M, et al. Complex segreation analysis of primary hepatocellular carcinoma in Chinese families: Interaction of inherited susceptibility and hepatitis B viral infection. Am J Hum Genet 1991;49:88-93.
30. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
31. Okamoto H, Okada S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990;60:215-222.
32. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981;78:3824-3828.
33. Chen DS, Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In: Okuda K, Ishak KG, (eds). Neoplasms of the Liver. Tokyo Heidelberg New York Berlin: Springer, 1987;71-80.
34. Chen DS, Kuo GC, Sung JL, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990;162:817-822.
35. Yu MW, You SL, Chang AS, et al. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51:5621-5625.
36. Pasternack MS. Cytotoxic T-lymphocytes. Adv Intern Med 1988;33:17-44.
37. Ehara T, Omata M, Yokosuka O, et al. Variations in codons S4 - 101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin Invest 1992;89:332-338.
38. Chuang WL, Omata M, Ehata T, et al. Precore mutations and core clustering mutations in chronic hepatitis B virus infection. Gastroenterology 1993;104:263-271.
39. Koziel MJ, Dudley D, Wong JT, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992;149:3339-3344.
40. Phillips RE, Rowland-Jones S, Nixon DF, et al. Human immunodeficiency virus gentic variation that can escape cytotoxic T cell recognition. Nature 1991;354:453-459.
41. Houghton M, Weiner A, Han J, et al. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 1991;14:381-388.
42. Kita H, Moriyama T, Kaneko T, et al. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 1993;18:1039-1044.
43. Shirai M, Akatsuka T, Pendleton CD, et al. Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J Virol 1992; 66:4098-4106.
44. Kumagai M. Genetic factors (HLA) and cellular immunity in the pathogenesis of asymptomatic HBsAg carriers (in Japanese). Acta Hepatol Jpn 1979;20:339-345.
45. Lin DY, Liaw YF, Chu CM, Chen GH. Histocompatibility profile of hepatoma in Taiwan. J Formosan Med Assoc (Taiwan 1 Hseuh Hui Tsa Chih) 1982;81:1126-1131.
46. Ravaggi A, Natoli G, Primi D, et al. Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells. J Hepatol 1994;20:833-836.
47. Suzuki R, Matsuura Y, Suzuki T, et al. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J Gen Virol 1995:76:53-61.
48. Shin C-M, Chen C-M, Chen S-Y, WuLee Y-H. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 1995;69:1160-1171.